[go: up one dir, main page]

NO20020829D0 - Ny anvendelse av docetaxel for behandling av hepatoma - Google Patents

Ny anvendelse av docetaxel for behandling av hepatoma

Info

Publication number
NO20020829D0
NO20020829D0 NO20020829A NO20020829A NO20020829D0 NO 20020829 D0 NO20020829 D0 NO 20020829D0 NO 20020829 A NO20020829 A NO 20020829A NO 20020829 A NO20020829 A NO 20020829A NO 20020829 D0 NO20020829 D0 NO 20020829D0
Authority
NO
Norway
Prior art keywords
docetaxel
treatment
hepatoma
new use
hepatocellular carcinoma
Prior art date
Application number
NO20020829A
Other languages
English (en)
Other versions
NO328527B1 (no
NO20020829L (no
Inventor
Chin-Wen Chi
Heng-Liang Lin
Tsung-Yun Liu
Wing-Yiu Liu
Gar-Yang Chau
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20020829D0 publication Critical patent/NO20020829D0/no
Publication of NO20020829L publication Critical patent/NO20020829L/no
Publication of NO328527B1 publication Critical patent/NO328527B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
NO20020829A 1999-08-31 2002-02-20 Ny anvendelse av docetaxel for behandling av hepatoma NO328527B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920548.6A GB9920548D0 (en) 1999-08-31 1999-08-31 Treatment of hepatocellular carcinoma
PCT/EP2000/008782 WO2001015675A2 (en) 1999-08-31 2000-08-29 Use of docetaxel for treating hepatocellular carcinoma

Publications (3)

Publication Number Publication Date
NO20020829D0 true NO20020829D0 (no) 2002-02-20
NO20020829L NO20020829L (no) 2002-02-20
NO328527B1 NO328527B1 (no) 2010-03-08

Family

ID=10860081

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020829A NO328527B1 (no) 1999-08-31 2002-02-20 Ny anvendelse av docetaxel for behandling av hepatoma

Country Status (34)

Country Link
US (2) US20030158249A1 (no)
EP (1) EP1214061B1 (no)
JP (1) JP4866522B2 (no)
KR (1) KR100670416B1 (no)
CN (1) CN1174748C (no)
AT (1) ATE269700T1 (no)
AU (1) AU777583B2 (no)
BG (1) BG65913B1 (no)
BR (1) BR0013625A (no)
CA (1) CA2382294C (no)
CZ (1) CZ301378B6 (no)
DE (1) DE60011794T2 (no)
DK (1) DK1214061T3 (no)
EA (1) EA004804B1 (no)
EE (1) EE05124B1 (no)
ES (1) ES2218223T3 (no)
GB (1) GB9920548D0 (no)
HK (1) HK1048944B (no)
HR (1) HRP20020171A2 (no)
HU (1) HU228861B1 (no)
IL (2) IL147489A0 (no)
ME (1) MEP7809A (no)
MX (1) MXPA02002041A (no)
NO (1) NO328527B1 (no)
NZ (1) NZ517604A (no)
PL (1) PL212612B1 (no)
PT (1) PT1214061E (no)
RS (1) RS50148B (no)
SI (1) SI1214061T1 (no)
SK (1) SK286378B6 (no)
TW (1) TW589180B (no)
UA (1) UA72927C2 (no)
WO (1) WO2001015675A2 (no)
ZA (1) ZA200201408B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1268619C (zh) 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
DE602004020506D1 (de) * 2003-12-12 2009-05-20 Quiral Quimica Do Brasil Verfahren zur herstellung von wasserfreien und hydratisierten pharmazeutischen wirkstoffen (apis); aus diesen hergestellte stabile pharmazeutische zusammensetzungen und anwendungen für diese zusammensetzungen
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
SI3311805T1 (sl) 2005-08-31 2020-07-31 Abraxis Bioscience, Llc Sestave, ki zajemajo slabo vodotopne farmacevtske učinkovine in antimikrobna sredstva
BRPI0615292A8 (pt) * 2005-08-31 2018-03-06 Abraxis Bioscience Llc composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
CN102014918A (zh) * 2007-04-20 2011-04-13 太阳医药工业有限公司 由微量沉淀产生的药学组合物
FR2917088B1 (fr) * 2007-06-08 2009-09-04 Aventis Pharma Sa Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
US8541360B2 (en) * 2008-11-19 2013-09-24 Ben Venue Laboratories, Inc. Parenteral formulations comprising sugar-based esters and ethers
LT2552438T (lt) 2010-03-26 2016-09-26 Abraxis Bioscience, Llc Hepatoceliulinės karcinomos gydymo būdai
AU2011248449B2 (en) * 2010-05-03 2016-09-15 Teikoku Pharma Usa, Inc. Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
US8842114B1 (en) 2011-04-29 2014-09-23 Nvidia Corporation System, method, and computer program product for adjusting a depth of displayed objects within a region of a display
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CA2976912A1 (en) * 2015-02-17 2016-08-25 Mallinckrodt Llc Modified docetaxel liposome formulations and uses thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
US5543154A (en) * 1991-12-27 1996-08-06 Merck & Co., Inc. Controlled release nifedipine delivery device
SG45369A1 (en) * 1993-01-19 1998-10-16 Warner Lambert Co Stable oral ci-981 formulation and process of preparing same
US5846945A (en) * 1993-02-16 1998-12-08 Onyx Pharmaceuticals, Inc. Cytopathic viruses for therapy and prophylaxis of neoplasia
US5436243A (en) * 1993-11-17 1995-07-25 Research Triangle Institute Duke University Aminoanthraquinone derivatives to combat multidrug resistance
FR2718963B1 (fr) * 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle composition pharmaceutique à base de taxoïdes.
FR2722191B1 (fr) * 1994-07-08 1996-08-23 Rhone Poulenc Rorer Sa Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
US6245805B1 (en) * 1995-10-26 2001-06-12 Baker Norton Pharmaceuticals, Inc. Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
FR2742751B1 (fr) * 1995-12-22 1998-01-30 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6471943B1 (en) * 1996-12-30 2002-10-29 Battelle Pulmonary Therapeutics, Inc. Formulation and method for treating neoplasms by inhalation
US6503893B2 (en) * 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
IL133672A0 (en) * 1997-06-27 2001-04-30 Vivorx Pharmaceuticals Inc Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US6544979B1 (en) * 1997-09-18 2003-04-08 Janssen Pharmaceuticals, N.V. Fused imidazole derivatives for improving oral bioavailability of pharmaceutical agents
WO1999022728A1 (en) * 1997-10-31 1999-05-14 Arch Development Corporation Methods and compositions for regulation of 5-alpha reductase activity
UA73092C2 (uk) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Таблетка з ентеросолюбільним покриттям і спосіб її приготування
PL350291A1 (en) * 1998-12-23 2002-12-02 Searle & Co Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives
CN101370774A (zh) * 2005-12-13 2009-02-18 特瓦制药工业有限公司 阿托伐他汀半钙的晶形及其制备方法

Also Published As

Publication number Publication date
HRP20020171A2 (en) 2004-02-29
PL212612B1 (pl) 2012-10-31
ATE269700T1 (de) 2004-07-15
AU7516800A (en) 2001-03-26
MXPA02002041A (es) 2002-08-20
BG65913B1 (bg) 2010-05-31
ME00624B (me) 2011-12-20
JP4866522B2 (ja) 2012-02-01
UA72927C2 (uk) 2005-05-16
HK1048944B (zh) 2005-04-22
EE05124B1 (et) 2009-02-16
RS50148B (sr) 2009-05-06
HK1048944A1 (en) 2003-04-25
GB9920548D0 (en) 1999-11-03
SK286378B6 (sk) 2008-08-05
NZ517604A (en) 2004-04-30
HUP0203197A2 (hu) 2003-01-28
CZ2002739A3 (cs) 2002-06-12
CZ301378B6 (cs) 2010-02-03
SK2712002A3 (en) 2002-07-02
NO328527B1 (no) 2010-03-08
HUP0203197A3 (en) 2005-01-28
EP1214061A2 (en) 2002-06-19
HU228861B1 (hu) 2013-06-28
CN1372466A (zh) 2002-10-02
PL353198A1 (en) 2003-11-03
BG106460A (bg) 2002-09-30
KR100670416B1 (ko) 2007-01-17
BR0013625A (pt) 2002-05-14
CA2382294C (en) 2008-06-03
WO2001015675A3 (en) 2001-09-20
JP2003508427A (ja) 2003-03-04
IL147489A (en) 2006-06-11
YU11402A (sh) 2005-07-19
EA004804B1 (ru) 2004-08-26
WO2001015675A2 (en) 2001-03-08
EP1214061B1 (en) 2004-06-23
DK1214061T3 (da) 2004-11-01
AU777583B2 (en) 2004-10-21
TW589180B (en) 2004-06-01
EA200200313A1 (ru) 2002-08-29
EE200200087A (et) 2003-04-15
CN1174748C (zh) 2004-11-10
SI1214061T1 (en) 2004-12-31
PT1214061E (pt) 2004-09-30
MEP7809A (en) 2011-12-20
KR20020060166A (ko) 2002-07-16
ES2218223T3 (es) 2004-11-16
US20030158249A1 (en) 2003-08-21
IL147489A0 (en) 2002-08-14
NO20020829L (no) 2002-02-20
ZA200201408B (en) 2003-07-30
CA2382294A1 (en) 2001-03-08
US20080045584A1 (en) 2008-02-21
DE60011794D1 (de) 2004-07-29
DE60011794T2 (de) 2005-07-14

Similar Documents

Publication Publication Date Title
NO20020829L (no) Ny anvendelse av docetaxel for behandling av hepatoma
DE60143393D1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
NO20034204D0 (no) Farmasöytiske kombinasjoner til behandling av kreft
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
ATE408601T1 (de) Fredericamycin-derivate
HUP0301405A2 (hu) Fokozott oldékonyságú gyógyhatású komponenseket tartalmazó készítmények
DE60124684D1 (de) Sulfonamido-substituierte verbrückte bicycloalkylderivative
MXPA05012323A (es) Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
SE9903759D0 (sv) Pharmaceutically active compounds
DE60204966D1 (de) Verwendung von cyclopamine zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis
ATE364595T1 (de) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
DE60128100D1 (de) Analgetisches arzneimittel
TR200102024T2 (tr) Yeni tedavi.
ATE411036T1 (de) Verwendung von aplidine in der behandlung von pankreaskrebs
NO20032597L (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
SE0000303D0 (sv) Novel compounds
DE60009315D1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
EA200700979A1 (ru) Пероральные твердые лекарственные формы, содержащие низкую дозу эстрадиола
ATE306940T1 (de) Zusammensetzung gegen coccidiose
ATE362480T1 (de) Phenanthridinderivate und phenanthridin enthaltende antitumorale arzneimittel
KR960021043A (ko) 스코폴레틴을 포함하는 b형 간염 치료제
UA34406A (uk) Засіб для лікування розсіяного склерозу, спосіб лікування з його використанням та фармацевтична упаковка
TW200744581A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees